Latest news
DNLI Q2 Loss Narrows, Avlayah Sales Drive Strong Launch Momentum - TradingViewTradingView · Fri, 07 Aug 2026 18:31:00 GMTUS FDA to hold advisory meeting to review Grail's multi-cancer test - TradingViewTradingView · Fri, 07 Aug 2026 15:23:21 GMTScholar Rock Q2 Earnings Call Highlights - TradingViewTradingView · Fri, 07 Aug 2026 13:04:04 GMTOcugen Q2 Earnings Call Highlights - TradingViewTradingView · Fri, 07 Aug 2026 06:04:10 GMTMRNA Stock Pares Gains Despite FDA Green Light For First mRNA Flu Vaccine — But Retail Cheers Pivot Beyond COVID - TradingViewTradingView · Thu, 06 Aug 2026 17:20:04 GMTViridian Therapeutics reports Q2 2026 net loss of $127.1M, cash $981.5M after Lumvoa FDA approval - TradingViewTradingView · Thu, 06 Aug 2026 11:13:01 GMTReplimune’s Melanoma FDA Decision Pending: This Analyst Sees 40% Upside, ‘High Conviction’ For Approval - TradingViewTradingView · Tue, 04 Aug 2026 10:44:37 GMTControl Bionics Secures FDA Registration for NeuroStrip Wearable Platform - TradingViewTradingView · Tue, 04 Aug 2026 02:21:00 GMT